Srinivas Shankara

1.9k total citations
27 papers, 1.3k citations indexed

About

Srinivas Shankara is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Srinivas Shankara has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Immunology and 8 papers in Oncology. Recurrent topics in Srinivas Shankara's work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers) and Virus-based gene therapy research (5 papers). Srinivas Shankara is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers) and Virus-based gene therapy research (5 papers). Srinivas Shankara collaborates with scholars based in United States, Japan and France. Srinivas Shankara's co-authors include Bruce Roberts, Johanne Kaplan, Paula Boutin, Susan Piraino, Sarah Pennington, Lisa Woodworth, William Weber, Beverly A. Teicher, Cécile Rouleau and Timothy Weeden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Srinivas Shankara

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Srinivas Shankara United States 18 660 595 297 202 200 27 1.3k
Fiorella Petronzelli Italy 18 391 0.6× 480 0.8× 252 0.8× 177 0.9× 200 1.0× 41 1.2k
Yutaka Kawakami Japan 17 672 1.0× 331 0.6× 452 1.5× 106 0.5× 191 1.0× 31 1.2k
Axel Mischo Switzerland 17 284 0.4× 427 0.7× 339 1.1× 96 0.5× 130 0.7× 40 900
G W Krissansen New Zealand 16 403 0.6× 473 0.8× 202 0.7× 84 0.4× 171 0.9× 28 1.1k
Brandon Harder United States 14 634 1.0× 372 0.6× 332 1.1× 180 0.9× 194 1.0× 19 1.4k
Sazuku Nisitani Japan 17 730 1.1× 485 0.8× 242 0.8× 124 0.6× 156 0.8× 20 1.4k
Barbara J. Schiemann United States 15 807 1.2× 685 1.2× 484 1.6× 129 0.6× 134 0.7× 17 1.8k
Aniruddha Choudhury Sweden 20 1.2k 1.8× 460 0.8× 909 3.1× 96 0.5× 185 0.9× 38 1.7k
Ranjani Rajapaksa United States 17 1.3k 2.0× 605 1.0× 807 2.7× 122 0.6× 221 1.1× 23 1.9k
Rebecca J. Brownlie United Kingdom 19 962 1.5× 543 0.9× 340 1.1× 193 1.0× 260 1.3× 25 1.5k

Countries citing papers authored by Srinivas Shankara

Since Specialization
Citations

This map shows the geographic impact of Srinivas Shankara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivas Shankara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivas Shankara more than expected).

Fields of papers citing papers by Srinivas Shankara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srinivas Shankara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivas Shankara. The network helps show where Srinivas Shankara may publish in the future.

Co-authorship network of co-authors of Srinivas Shankara

This figure shows the co-authorship network connecting the top 25 collaborators of Srinivas Shankara. A scholar is included among the top collaborators of Srinivas Shankara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srinivas Shankara. Srinivas Shankara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Hongwei, Jennifer Johnson, Joseph Gans, et al.. (2023). Cellular mechanisms and effects of IL-4 receptor blockade in experimental conjunctivitis evoked by skin inflammation. JCI Insight. 8(3). 5 indexed citations
2.
Kühle, Jens, Nadia Daizadeh, Pascal Benkert, et al.. (2021). Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS. Multiple Sclerosis Journal. 28(4). 573–582. 26 indexed citations
3.
Han, Yingnan, Erin Teeple, Srinivas Shankara, et al.. (2021). Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk (4286). Neurology. 96(15_supplement). 2 indexed citations
4.
Zhang, Mindy, Yi-Chien Chang, Srinivas Shankara, et al.. (2019). Characterization of the Peripheral Blood Transcriptome in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients From the CARE-MS I and II Studies (P4.2-041). Neurology. 92(15_supplement). 1 indexed citations
5.
Rao, Sambasiva P., José Sancho, Paula Boutin, et al.. (2012). Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis. PLoS ONE. 7(6). e39416–e39416. 140 indexed citations
6.
Nguyen, Tri‐Hung, William Weber, Evis Havari, et al.. (2012). Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia. International Journal of Oncology. 41(3). 829–838. 15 indexed citations
7.
Nguyen, Tri‐Hung, Evis Havari, Mindy Zhang, et al.. (2011). Alemtuzumab induction of intracellular signaling and apoptosis in malignant B lymphocytes. Leukemia & lymphoma. 53(4). 699–709. 10 indexed citations
8.
Siders, William, Jacqueline D. Shields, Yanping Hu, et al.. (2010). Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models. Leukemia & lymphoma. 51(7). 1293–1304. 61 indexed citations
9.
Nguyen, Tri‐Hung, Evis Havari, Rebecca G. Bagley, et al.. (2009). Abstract C166: Cancer cells expressing TMPRSS4 colocalized with carbonic anhydrase IX (CAIX)-positive cells in lung and pancreatic carcinomas. Molecular Cancer Therapeutics. 8(12_Supplement). C166–C166. 1 indexed citations
10.
Bagley, Rebecca G., Nakayuki Honma, William Weber, et al.. (2008). Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. Microvascular Research. 76(3). 180–188. 78 indexed citations
11.
Bagley, Rebecca G., Cécile Rouleau, Thia St Martin, et al.. (2008). Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248. Molecular Cancer Therapeutics. 7(8). 2536–2546. 42 indexed citations
12.
Ruzek, Melanie C., Deborah Hopkins, Jennifer C. Sullivan, et al.. (2007). Characterization of in vitro antimurine thymocyte globulin–induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood. 111(3). 1726–1734. 40 indexed citations
13.
Zhou, Qun, Srinivas Shankara, André Roy, et al.. (2007). Development of a simple and rapid method for producing non‐fucosylated oligomannose containing antibodies with increased effector function. Biotechnology and Bioengineering. 99(3). 652–665. 149 indexed citations
14.
Bagley, Rebecca G., Cécile Rouleau, Sharon D. Morgenbesser, et al.. (2006). Pericytes from human non-small cell lung carcinomas: An attractive target for anti-angiogenic therapy. Microvascular Research. 71(3). 163–174. 30 indexed citations
15.
Jiang, Canwen, Hsienwie Lu, Karen A. Vincent, et al.. (2002). Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1α. Physiological Genomics. 8(1). 23–32. 48 indexed citations
16.
Housseau, Franck, Monica I. Gonzales, Paula Boutin, et al.. (2002). Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients. Journal of Immunological Methods. 266(1-2). 87–103. 19 indexed citations
17.
Krohne, Tim U., Srinivas Shankara, Michael Geißler, et al.. (2001). Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro. Hepatology. 34(3). 511–518. 51 indexed citations
18.
Mohr, Leonhard, Tim U. Krohne, Srinivas Shankara, et al.. (2001). Mechanisms of cell death induced by the suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro. Journal of Hepatology. 34. 107–108. 1 indexed citations
19.
Linette, Gerald P., Srinivas Shankara, Simonne Longerich, et al.. (2000). In Vitro Priming with Adenovirus/gp100 Antigen-Transduced Dendritic Cells Reveals the Epitope Specificity of HLA-A*0201-Restricted CD8+ T Cells in Patients with Melanoma. The Journal of Immunology. 164(6). 3402–3412. 47 indexed citations
20.
Perricone, Michael A., Karen Smith, Johanne Kaplan, et al.. (2000). Immunogene Therapy for Murine Melanoma Using Recombinant Adenoviral Vectors Expressing Melanoma-Associated Antigens. Molecular Therapy. 1(3). 275–284. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026